top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Autore Allison Simon J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (206 p.)
Soggetto topico Technology: general issues
History of engineering & technology
Soggetto non controllato microtubule acetylation
triple-negative breast cancer
anti-cancer agent
apoptosis
K562
8-hydroxydaidzein
autophagy
BCR-ABL
MAPK
NF-κB
c-myc
RNA interference
siRNA
oncogene
gene silencing
expression
nanosystems
Cytochrome P450
CYP1A1
CYP1B1
CYP2W1
breast cancer
prodrug
bioprecursor
duocarmycin
phortress
AQ4N
5-FU resistance
colorectal cancer
drug repurposing
Genomics of Drug Sensitivity in Cancer
Connectivity Map
anticancer drug
B-lactam steroid alkylators
synthetic lethality
poly (ADP-ribose) polymerase inhibitors
ovarian cancer
hybrid steroidal alkylating agents
migration
invasion
glioblastoma
CCN1
mesenchymal-amoeboid transition
biomarker
HepG2
Huh7
isatin sulfonamides
angiogenesis
cancer hallmarks
molecular docking
EGFR tyrosine kinase inhibitor
photon upconversion
triplet-triplet annihilation
in vivo imaging
PLGA
nanoparticles
affibody molecule
human epidermal growth factor receptor 3 (HER3)
BxPC-3
emtansine
DM1
albumin binding domain
affibody drug conjugate (AffiDC)
ISBN 3-0365-5222-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Novel Anti-cancer Agents and Cellular Targets and Their Mechanism
Record Nr. UNINA-9910619465503321
Allison Simon J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Radiopharmaceuticals for PET Imaging - Issue A
Radiopharmaceuticals for PET Imaging - Issue A
Autore Roivainen Anne
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (212 p.)
Soggetto topico Medicine
Soggetto non controllato kinetic analysis
Siglec-9
gallium-68
vascular adhesion protein
VAP-1
infection
inflammation
osteomyelitis
animal model
Staphylococcus aureus
multiple myeloma
positron emission tomography/computed tomography
radiopharmaceuticals
18F-fluorodeoxyglucose
tetrazine ligation
PET
SPECT
indium-11
fluorine-18
positron emission tomography (PET), defluorination
isotopic exchange
silicon-based fluoride acceptor
bioorthogonal chemistry
tetrazine
inverse electron-demand Diels-Alder ligation
opioid
naloxone
overdose
fentanyl
carfentanil
[11C]carfentanil
positron emission tomography
receptor occupancy
pharmacokinetics
[18F]AlF
NOTA
NODAGA
PODS
thiol-reactive
linker
affibody molecule
bioconjugation
EGFR
tumor imaging
vulnerable plaque
molecular imaging
PET imaging
nanobody
single-domain antibody
sub-millimetre resolution
AlF-radiolabelling
preclinical radiopharmaceutical dosimetry
image-based internal dosimetry
OLINDA
MCT1/MCT4 lactate transporter inhibitor
[18F]FACH
radiation safety
sigma-1 receptor availability
orthotopic xenograft of glioblastoma in mouse
small animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)
(S)-(−)-[18F]fluspidine
imaging-based biomarker
SV2A protein
PET radiotracers
synaptic loss
radiochemistry
preclinical development
clinical outcomes
monocarboxylate transporters (MCTs)
FACH
18F-labeled analog of FACH
α-CCA
blood-brain barrier (BBB)
positron emission tomography (PET) imaging
peptides
proteolysis
metabolic stability
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557437003321
Roivainen Anne  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui